Displaying 1–23 of 23 results for Katie Weiler, Managing Editor
FDA aims to make its risk evaluation and mitigation strategy easier, and changes are in the works to help manufacturers meet the required safety measures
A look at Downstream Bioprocessing Trends
Although FDA can’t control prescription drug pricing, it can and will facilitate increased drug competition through faster approval of lower-cost, generic medicines
Product Focus: Environmental Controls -- Pharma manufacturers must optimize their operations and controls — while adhering to strict regulatory guidelines — in order to maintain quality and increase efficiency.
For those who argue that the FDA is either overprotecting or underprotecting the public, or take issue with FDA processes and regulations, let your voices be heard while regulators are listening
In this case, an FDA delay is a good thing, as it offers temporary relief to pharma manufacturers by not enforcing the deadline of DSCSA for an entire year
Pharma’s All-Star tech lineup shatters records with plenty of hits.
In FDA’s world, ET does not refer to The Extra-Terrestrial as made famous by the movie, but rather Emerging Technologies, and it set up a special task force to facilitate pharmaceutical innovation
Pharmaceutical manufacturers may not be looking forward to FDA’s Cinco de Mayo deadline, but if they don’t file electronically, their drug submissions will be rejected
The FDA has taken several actions to help reduce the number of people who become addicted, or who ultimately overdose from prescription opioids
FDA implements initiatives to speed drug approvals, labeling changes and delivery
Detection systems range from laser-induced fluorescence that measures particle size and determines whether a particle is biologic or inert, to non-destructive enumeration technology, to identifying stable viruses without a membrane envelope
Attendees participated in more than 400 sessions and forums, technology exhibits, certified professional development and more
A virtual panel of four contract manufacturing organization thought leaders shares what it takes to be competitive in todays challenging market
Have you taken your vitals on the latest in digital health technology? If not, it might be time to put on the cuff for an examination.
According to a recent keynote address by Jane McGonigal, gaming has a huge growth potential in the pharmaceutical industry
First trivalent influenza vaccine based on insect-based recombinant DNA technology
Many mixers on the market can perform different tasks, but certain products are necessary to meet specific requirements
Acquisition of systems integrator Vialis brings expertise in delivering paperless laboratory solutions
An assortment of pump and valve innovations help provide clean process efficiencies.